Efficacy and safety of ustekinumab in Behçet disease: Results from the prospective phase 2 STELABEC trial

Affiliations

¹ Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France; Université de Paris, France.
² Unité de Recherche Clinique Centre d'Investigation Clinique, Paris Descartes Necker/Cochin, Hôpital Tarnier, France.
³ Department of Dermatology, Hôpital-Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁴ Department of Internal Medicine, Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France.
⁵ Sorbonne Université, Service de Médecine Interne 2, Centre de Référence National Lupus Systémique et Syndromes des anti-phospholipides et Autres Maladies Auto-immunes et Systémiques Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, France.
⁶ Université de Paris, France; Department of Dermatology, Hôpital Cochin, AP-HP, Paris, France.
⁷ Department of Internal Medicine, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Reims, France.
⁸ Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁹ Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France; Université de Paris, France. Electronic address: benjamin.terrier@aphp.fr.

Clinical Trial

Jonathan London et al. J Am Acad Dermatol. 2022 Sep.

. 2022 Sep;87(3):681-684.

doi: 10.1016/j.jaad.2021.11.045. Epub 2021 Dec 2.

¹ Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France; Université de Paris, France.
² Unité de Recherche Clinique Centre d'Investigation Clinique, Paris Descartes Necker/Cochin, Hôpital Tarnier, France.
³ Department of Dermatology, Hôpital-Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁴ Department of Internal Medicine, Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France.
⁵ Sorbonne Université, Service de Médecine Interne 2, Centre de Référence National Lupus Systémique et Syndromes des anti-phospholipides et Autres Maladies Auto-immunes et Systémiques Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, France.
⁶ Université de Paris, France; Department of Dermatology, Hôpital Cochin, AP-HP, Paris, France.
⁷ Department of Internal Medicine, Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré, Reims, France.
⁸ Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁹ Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France; Université de Paris, France. Electronic address: benjamin.terrier@aphp.fr.

No abstract available

Conflict of interest statement

Conflicts of interest None disclosed.